Press release
Curetis Expects Near-Term FDA Decision on De Novo Request
08 Jan 2018 07:28 CET
Company Name
CURETIS
ISIN
NL0011509294
Connect_20180108_cure_pr_fda_update_en_approved.pdf
Connect_20180108_cure_pr_fda_update_de_approved.pdf